ZA935575B - Therapeutic agent and its use. - Google Patents

Therapeutic agent and its use.

Info

Publication number
ZA935575B
ZA935575B ZA935575A ZA935575A ZA935575B ZA 935575 B ZA935575 B ZA 935575B ZA 935575 A ZA935575 A ZA 935575A ZA 935575 A ZA935575 A ZA 935575A ZA 935575 B ZA935575 B ZA 935575B
Authority
ZA
South Africa
Prior art keywords
therapeutic agent
therapeutic
agent
Prior art date
Application number
ZA935575A
Other languages
English (en)
Inventor
John Lawson Stanford
Graham Arthur William Rook
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Publication of ZA935575B publication Critical patent/ZA935575B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA935575A 1992-09-14 1993-08-02 Therapeutic agent and its use. ZA935575B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929219425A GB9219425D0 (en) 1992-09-14 1992-09-14 Therapeutic agent and its use

Publications (1)

Publication Number Publication Date
ZA935575B true ZA935575B (en) 1994-03-01

Family

ID=10721884

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA935575A ZA935575B (en) 1992-09-14 1993-08-02 Therapeutic agent and its use.

Country Status (17)

Country Link
EP (1) EP0661998B1 (de)
JP (1) JPH06100457A (de)
KR (1) KR100272743B1 (de)
CN (1) CN1060937C (de)
AP (1) AP510A (de)
AT (1) ATE173633T1 (de)
AU (1) AU683835B2 (de)
BR (1) BR9303762A (de)
CA (1) CA2105646A1 (de)
DE (1) DE69322280T2 (de)
DK (1) DK0661998T3 (de)
ES (1) ES2125331T3 (de)
GB (1) GB9219425D0 (de)
RU (1) RU2106878C1 (de)
SG (1) SG72610A1 (de)
WO (1) WO1994006466A1 (de)
ZA (1) ZA935575B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
KR100533818B1 (ko) * 1996-12-18 2005-12-07 스탠포드 룩 리미티드 면역계의 ｔｈ2 활성의 하향 조절을 위한 마이코박테리움 박케
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
GB9903539D0 (en) * 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
UA77666C2 (en) * 2001-01-17 2007-01-15 Kabulesh Mafatlal Khamar Use of mycobacterium w or its components in preparations for treating hiv infection
DE60231605D1 (de) * 2001-01-17 2009-04-30 Bakulesh Mafatlal Khamar Immunomodulator zur bekämpfung von durch humanen immunschwächevirus (hiv) vermittelte krankheiten/infektionen
EP1478391A1 (de) * 2002-01-29 2004-11-24 Bakulesh Mafatlal Khamar Verfahren zur prophylaxe von tuberkulose bei hiv-positiven personen
WO2003063896A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv, Indravadan Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals
AU2003209534A1 (en) * 2002-03-08 2003-09-22 Bakulesh Mafatlal Khamar The method of treating tuberculosis
RU2380114C1 (ru) * 2008-06-25 2010-01-27 Людмила Анатольевна Шовкун Способ лечения туберкулеза легких у больных вич-инфекцией
JP7760151B2 (ja) * 2021-09-09 2025-10-27 国立大学法人東京海洋大学 抗酸菌症用ｄｎａワクチン及びそれを用いた抗酸菌症の予防方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3728367C1 (de) * 1987-08-25 1988-09-01 Burkhard Steglich Mittel zur Immunisierung des menschlichen Koerpers bei HIV-Infektionen
GB8917256D0 (en) * 1989-07-28 1989-09-13 Univ London Biological preparation and its use

Also Published As

Publication number Publication date
EP0661998A1 (de) 1995-07-12
JPH06100457A (ja) 1994-04-12
RU2106878C1 (ru) 1998-03-20
DE69322280D1 (de) 1999-01-07
BR9303762A (pt) 1994-03-22
AP9300555A0 (en) 1993-10-31
SG72610A1 (en) 2001-07-24
ES2125331T3 (es) 1999-03-01
AP510A (en) 1996-07-23
CA2105646A1 (en) 1994-03-15
GB9219425D0 (en) 1992-10-28
KR950703360A (ko) 1995-09-20
CN1060937C (zh) 2001-01-24
HK1011289A1 (en) 1999-07-09
WO1994006466A1 (en) 1994-03-31
EP0661998B1 (de) 1998-11-25
DE69322280T2 (de) 1999-04-22
AU683835B2 (en) 1997-11-27
DK0661998T3 (da) 1999-08-09
CN1089478A (zh) 1994-07-20
KR100272743B1 (ko) 2000-11-15
ATE173633T1 (de) 1998-12-15
AU3642093A (en) 1994-04-12

Similar Documents

Publication Publication Date Title
IL101038A0 (en) Agent specific for trombin and its use
PL297979A1 (en) Therapeutic agent coupled with asialoglycoproteine
ZA935575B (en) Therapeutic agent and its use.
GB9200781D0 (en) Therapeutic agents
GB9319772D0 (en) Therapeutic agent
ZA933815B (en) Pyrimidinyl- and triazinyl-salicyl- and -picolyl- amides and the use and preparation thereof.
GB9412618D0 (en) Cytotoxic agent and its use
ZA932458B (en) Naphtoquinones and their use.
GB9501907D0 (en) Allatostatins and their use
GB9314512D0 (en) Composition and use
GB9412689D0 (en) Cytotoxic agent and its use
ZW5093A1 (en) Sensitizer and use
GB2451221B (en) Azidoalkylformals, their prepararion and use
GB9213538D0 (en) Therapeutic agent
ZA928102B (en) Therapeutic agent.
GB9226056D0 (en) Therapeutic use
GB9226047D0 (en) Therapeutic use
GB9220714D0 (en) Therapeutic use
ZA924842B (en) Asialoglycoprotein-conjugated medicinal agent
ZA923422B (en) Therapeutic agent
GB9122204D0 (en) Therapeutic agent
GB9112058D0 (en) Therapeutic agent
GB9321063D0 (en) Analgesic agent and its use
GB9210595D0 (en) Medical use
GB9210576D0 (en) Medical use